RA
LMAT icon

Royce & Associates’s LeMaitre Vascular LMAT Stock Holding History

Royce & Associates’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,582
Closed -$391K – 802
2026
Q1 		$391K Buy
+3,582
New +$341K ﹤0.01% 722
2024
Q1 		– Sell
-9,200
Closed -$522K – 908
2023
Q4 		$522K Buy
+9,200
New +$482K ﹤0.01% 789
2022
Q4 		– Sell
-5,134
Closed -$260K – 935
2022
Q3 		$260K Sell
5,134
-3,737
-42% -$187K ﹤0.01% 875
2022
Q2 		$404K Buy
8,871
+114
+1% +$5.1K ﹤0.01% 856
2022
Q1 		$407K Buy
+8,757
New +$392K ﹤0.01% 899
2021
Q2 		– Sell
-14,620
Closed -$713K – 1027
2021
Q1 		$713K Sell
14,620
-5,020
-26% -$235K ﹤0.01% 892
2020
Q4 		$795K Buy
19,640
+4,216
+27% +$151K 0.01% 837
2020
Q3 		$502K Buy
15,424
+5,368
+53% +$161K 0.01% 861
2020
Q2 		$265K Buy
10,056
+4,027
+67% +$105K ﹤0.01% 912
2020
Q1 		$150K Buy
6,029
+83
+1% +$2.56K ﹤0.01% 949
2019
Q4 		$214K Sell
5,946
-64
-1% -$2.21K ﹤0.01% 966
2019
Q3 		$205K Buy
6,010
+199
+3% +$6.36K ﹤0.01% 975
2019
Q2 		$163K Buy
5,811
+40
+0.7% +$1.11K ﹤0.01% 997
2019
Q1 		$179K Sell
5,771
-75,876
-93% -$2.02M ﹤0.01% 1001
2018
Q4 		$1.93M Buy
81,647
+14,009
+21% +$383K 0.02% 741
2018
Q3 		$2.62M Sell
67,638
-15,736
-19% -$567K 0.02% 771
2018
Q2 		$2.79M Buy
83,374
+39,683
+91% +$1.41M 0.02% 755
2018
Q1 		$1.58M Buy
43,691
+38,471
+737% +$1.33M 0.01% 893
2017
Q4 		$166K Buy
5,220
+51
+1% +$1.75K ﹤0.01% 1091
2017
Q3 		$193K Buy
5,169
+169
+3% +$5.75K ﹤0.01% 1072
2017
Q2 		$156K Buy
+5,000
New +$144K ﹤0.01% 1084
2015
Q4 		– Sell
-9,900
Closed -$121K – 1150
2015
Q3 		$121K Hold
9,900
– – ﹤0.01% 1121
2015
Q2 		$119K Hold
9,900
– – ﹤0.01% 1148
2015
Q1 		$83K Buy
+9,900
New +$77.7K ﹤0.01% 1167

Other funds holding LMAT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Royce & Associates's LMAT Position: Q2 2026 in Review

Royce & Associates sold out of LeMaitre Vascular (LMAT) in Q2 2026, closing a stake of 3,582 shares — an estimated $391K sold.

Royce & Associates first reported a position in LMAT in Q1 2015 and held it in 24 quarters. The position peaked at $2.79M in Q2 2018. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

  • Royce & Associates reported no remaining LeMaitre Vascular position as of Q2 2026 after selling out during the quarter.
  • Royce & Associates sold 3,582 LeMaitre Vascular shares in Q2 2026, an estimated $391K.
  • Royce & Associates first reported a position in LeMaitre Vascular in Q1 2015 and held it in 24 quarters.
  • Royce & Associates's LeMaitre Vascular position peaked at $2.79M in Q2 2018.
  • 326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Royce & Associates's 13F filing for Q2 2026, filed 14 Aug 2026.